Harvard Bioscience (HBIO) Change in Account Payables (2010 - 2020)
Harvard Bioscience (HBIO) reported Change in Account Payables of -$154000.0 for Q4 2020, down 1500.0% year-over-year from $11000.0 in Q1 2020, and up 73.68% quarter-over-quarter from -$585000.0 in Q3 2020.
Harvard Bioscience (HBIO) Change in Account Payables (2010 - 2020) Analysis & Trends
Harvard Bioscience (HBIO) has 11 years of Change in Account Payables data on file, last reported at -$154000.0 in Q4 2020.
- Change in Account Payables for Q4 2020 came in at -$154000.0, down 1500.0% year-over-year; the trailing twelve-month figure through Dec 2020 was $511000.0 (up 124.95% YoY), and the FY2020 annual result was $511000.0, up 124.95% from the prior year.
- Change in Account Payables grew to -$154000.0 in Q4 2020 per HBIO's latest filing, from -$585000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $2.0 million in Q4 2018 and troughed at -$2.7 million in Q1 2016.
- A 5-year average of -$163750.0 and a median of -$125000.0 in 2017 frame the typical range for Change in Account Payables.
- On a YoY basis, Change in Account Payables climbed as much as 1641.67% in 2018 and fell as far as 2598.8% in 2018.
- A 5-year view of Change in Account Payables shows it stood at $372000.0 in 2016, then tumbled by 135.48% to -$132000.0 in 2017, then soared by 1641.67% to $2.0 million in 2018, then plunged by 99.46% to $11000.0 in 2019, then sank by 1500.0% to -$154000.0 in 2020.
- Business Quant data shows HBIO's Change in Account Payables at -$154000.0 in Q4 2020, -$585000.0 in Q3 2020, and -$72000.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 73.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 6.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 23.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 4.93 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 102.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -154,000.00 |
| Dec 31, 2020 | -154,000.00 |
| Sep 30, 2020 | -585,000.00 |
| Sep 30, 2020 | -585,000.00 |
| Jun 30, 2020 | -72,000.00 |
| Jun 30, 2020 | -72,000.00 |
| Mar 31, 2020 | 1.32 Mn |
| Mar 31, 2020 | 1.32 Mn |
| Dec 31, 2019 | 11,000.00 |
| Dec 31, 2019 | 11,000.00 |
| Sep 30, 2019 | -677,000.00 |
| Sep 30, 2019 | -677,000.00 |
| Jun 30, 2019 | -1.26 Mn |
| Jun 30, 2019 | -1.26 Mn |
| Mar 31, 2019 | -118,000.00 |
| Mar 31, 2019 | -118,000.00 |
| Dec 31, 2018 | 2.04 Mn |
| Dec 31, 2018 | 2.04 Mn |
| Sep 30, 2018 | -2.24 Mn |
| Sep 30, 2018 | -2.24 Mn |